US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
Year: 2025
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-25-01369
Authors: Nina Kim, E. Dianne Pulte, Lori A. Ehrlich, Alexei C. Ionan, Spencer Haupert, Jonathon Vallejo, Francis Green, Nan Zheng, Yun Wang, Jiang Liu, Javier G. Blanco, Sarah E. Dorff, Brian Booth, Moran Choe, Brenda Gehrke, Vishal Bhatnagar, Marc Theoret, Richard Pazdur, R. Angelo De Claro, Kelly J. Norsworthy
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
Award: G3050811832
OpenAlex ID: W4415526908